United States · FDA National Drug Code directory
Astringent
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63561-0178_37553cf5-a897-fef9-e063-6394a90a7812
- Product NDC
- 63561-0178
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate
- Labeler
- Granulation Technology, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250612
- Source listing expiry
- 20261231
Source-listed ingredients
- CALCIUM ACETATE MONOHYDRATE — 952 mg/2299mg
- ALUMINUM SULFATE TETRADECAHYDRATE — 1347 mg/2299mg
These values do not establish equivalence or a dose recommendation.
Packages
- 12 PACKET in 1 CARTON (63561-0178-2) / 2299 mg in 1 PACKET (63561-0178-1) · 63561-0178-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →